Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

519 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Mild hypothermia provides Treg stability.
Marek-Trzonkowska N, Piekarska K, Filipowicz N, Piotrowski A, Gucwa M, Vogt K, Sawitzki B, Siebert J, Trzonkowski P. Marek-Trzonkowska N, et al. Among authors: siebert j. Sci Rep. 2017 Sep 20;7(1):11915. doi: 10.1038/s41598-017-10151-1. Sci Rep. 2017. PMID: 28931834 Free PMC article.
Author Correction: Mild hypothermia provides Treg stability.
Marek-Trzonkowska N, Piekarska K, Filipowicz N, Piotrowski A, Gucwa M, Vogt K, Sawitzki B, Siebert J, Trzonkowski P. Marek-Trzonkowska N, et al. Among authors: siebert j. Sci Rep. 2017 Dec 15;7(1):17940. doi: 10.1038/s41598-017-17186-4. Sci Rep. 2017. PMID: 29247202 Free PMC article.
Clinical application of regulatory T cells in type 1 diabetes.
Marek-Trzonkowska N, Myśliwec M, Siebert J, Trzonkowski P. Marek-Trzonkowska N, et al. Among authors: siebert j. Pediatr Diabetes. 2013 Aug;14(5):322-32. doi: 10.1111/pedi.12029. Epub 2013 Apr 30. Pediatr Diabetes. 2013. PMID: 23627860 Review.
Therapy of type 1 diabetes with CD4(+)CD25(high)CD127-regulatory T cells prolongs survival of pancreatic islets - results of one year follow-up.
Marek-Trzonkowska N, Myśliwiec M, Dobyszuk A, Grabowska M, Derkowska I, Juścińska J, Owczuk R, Szadkowska A, Witkowski P, Młynarski W, Jarosz-Chobot P, Bossowski A, Siebert J, Trzonkowski P. Marek-Trzonkowska N, et al. Among authors: siebert j. Clin Immunol. 2014 Jul;153(1):23-30. doi: 10.1016/j.clim.2014.03.016. Epub 2014 Apr 1. Clin Immunol. 2014. PMID: 24704576 Clinical Trial.
Mesenchymal stem cells transfer mitochondria to allogeneic Tregs in an HLA-dependent manner improving their immunosuppressive activity.
Piekarska K, Urban-Wójciuk Z, Kurkowiak M, Pelikant-Małecka I, Schumacher A, Sakowska J, Spodnik JH, Arcimowicz Ł, Zielińska H, Tymoniuk B, Renkielska A, Siebert J, Słomińska E, Trzonkowski P, Hupp T, Marek-Trzonkowska NM. Piekarska K, et al. Among authors: siebert j. Nat Commun. 2022 Feb 14;13(1):856. doi: 10.1038/s41467-022-28338-0. Nat Commun. 2022. PMID: 35165293 Free PMC article.
Factors affecting long-term efficacy of T regulatory cell-based therapy in type 1 diabetes.
Marek-Trzonkowska N, Myśliwiec M, Iwaszkiewicz-Grześ D, Gliwiński M, Derkowska I, Żalińska M, Zieliński M, Grabowska M, Zielińska H, Piekarska K, Jaźwińska-Curyłło A, Owczuk R, Szadkowska A, Wyka K, Witkowski P, Młynarski W, Jarosz-Chobot P, Bossowski A, Siebert J, Trzonkowski P. Marek-Trzonkowska N, et al. Among authors: siebert j. J Transl Med. 2016 Dec 1;14(1):332. doi: 10.1186/s12967-016-1090-7. J Transl Med. 2016. PMID: 27903296 Free PMC article. Clinical Trial.
Proinsulin-specific T regulatory cells may control immune responses in type 1 diabetes: implications for adoptive therapy.
Gliwiński M, Iwaszkiewicz-Grześ D, Wołoszyn-Durkiewicz A, Tarnowska M, Żalińska M, Hennig M, Zielińska H, Dukat-Mazurek A, Zielkowska-Dębska J, Zieliński M, Jaźwińska-Curyłło A, Owczuk R, Jarosz-Chobot P, Bossowski A, Szadkowska A, Młynarski W, Marek-Trzonkowska N, Moszkowska G, Siebert J, Myśliwiec M, Trzonkowski P. Gliwiński M, et al. Among authors: siebert j. BMJ Open Diabetes Res Care. 2020 Feb;8(1):e000873. doi: 10.1136/bmjdrc-2019-000873. BMJ Open Diabetes Res Care. 2020. PMID: 32098895 Free PMC article.
Combined therapy with CD4+ CD25highCD127- T regulatory cells and anti-CD20 antibody in recent-onset type 1 diabetes is superior to monotherapy: Randomized phase I/II trial.
Zieliński M, Żalińska M, Iwaszkiewicz-Grześ D, Gliwiński M, Hennig M, Jaźwińska-Curyłło A, Kamińska H, Sakowska J, Wołoszyn-Durkiewicz A, Owczuk R, Młynarski W, Jarosz-Chobot P, Bossowski A, Szadkowska A, Siebert J, Myśliwiec M, Marek-Trzonkowska N, Trzonkowski P. Zieliński M, et al. Among authors: siebert j. Diabetes Obes Metab. 2022 Aug;24(8):1534-1543. doi: 10.1111/dom.14723. Epub 2022 May 9. Diabetes Obes Metab. 2022. PMID: 35441440 Clinical Trial.
519 results